These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 8346077
1. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Kennedy AR, Szuhaj BF, Newberne PM, Billings PC. Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077 [Abstract] [Full Text] [Related]
2. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Kennedy AR, Billings PC, Wan XS, Newberne PM. Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698 [Abstract] [Full Text] [Related]
7. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans. Maki PA, Paterson Y, Kennedy AR. Nutr Cancer; 1994 Sep; 22(2):185-93. PubMed ID: 14502847 [Abstract] [Full Text] [Related]
8. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent. Ekrami H, Kennedy AR, Witschi H, Shen WC. J Drug Target; 1993 Sep; 1(1):41-9. PubMed ID: 8069543 [Abstract] [Full Text] [Related]
11. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR. Nutr Cancer; 1999 Sep; 33(2):165-73. PubMed ID: 10368812 [Abstract] [Full Text] [Related]
12. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum. Kennedy CW, Donahue JJ, Wan XS. Nutr Cancer; 1996 Sep; 26(2):209-17. PubMed ID: 8875558 [Abstract] [Full Text] [Related]
13. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells. Wan XS, Hamilton TC, Ware JH, Donahue JJ, Kennedy AR. Nutr Cancer; 1998 Sep; 31(1):8-17. PubMed ID: 9682243 [Abstract] [Full Text] [Related]
14. Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor. Wan XS, Meyskens FL, Armstrong WB, Taylor TH, Kennedy AR. Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):601-8. PubMed ID: 10428197 [Abstract] [Full Text] [Related]
20. Imbibition of soybean seeds in warm water results in the release of copious amounts of Bowman-Birk protease inhibitor, a putative anticarcinogenic agent. Palavalli MH, Natarajan SS, Wang TT, Krishnan HB. J Agric Food Chem; 2012 Mar 28; 60(12):3135-43. PubMed ID: 22372424 [Abstract] [Full Text] [Related] Page: [Next] [New Search]